184 related articles for article (PubMed ID: 7378650)
1. Increases in aggregation by and uptake of 5-hydroxytryptamine with platelets from rabbits treated with chlorpromazine.
Baldacci M; Baldacci M; Bergel TD; Born GV; Hickman M
Br J Pharmacol; 1980 May; 69(1):113-8. PubMed ID: 7378650
[TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxytryptamine uptake and release in relation to aggregation of rabbit platelets.
Baumgartner HR
J Physiol; 1969 Apr; 201(2):409-23. PubMed ID: 5780550
[TBL] [Abstract][Full Text] [Related]
3. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
4. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine.
Boullin DJ; Woods HF; Grimes RP; Grahame-Smith DG
Br J Clin Pharmacol; 1975 Feb; 2(1):29-35. PubMed ID: 791316
[TBL] [Abstract][Full Text] [Related]
6. Resuspension of platelets: enhanced 5-hydroxytryptamine-induced aggregation in chlorpromazine treated patients due to changes in platelet properties.
Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
Br J Clin Pharmacol; 1975 Feb; 2(1):37-9. PubMed ID: 791317
[TBL] [Abstract][Full Text] [Related]
7. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
Oppenheim B; Hefez A; Youdim MB
Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 5-hydroxytryptamine-induced human blood platelet aggregation by chlorpromazine and its metabolites.
Boullin DJ; Grahame-Smith DG; Grimes RP; Woods HF
Br J Pharmacol; 1975 Jan; 53(1):121-5. PubMed ID: 1125484
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
10. Effects of chlorpromazine on serotonin uptake in blood platelets.
Arora RC; Meltzer HY
Psychiatry Res; 1983 May; 9(1):23-8. PubMed ID: 6577481
[TBL] [Abstract][Full Text] [Related]
11. The relation between the 5-hydroxytryptamine content and aggregation of rabbit platelets.
Baumgartner HR; Born GV
J Physiol; 1969 Apr; 201(2):397-408. PubMed ID: 5780549
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
Glusa E; Markwardt F
Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aggregation of rabbit and human platelets induced by adrenaline and 5-hydroxytryptamine by KB-R7943, a Na(+)/Ca(2+) exchange inhibitor.
Takano S; Kimura J; Ono T
Br J Pharmacol; 2001 Apr; 132(7):1383-8. PubMed ID: 11264230
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet aggregation in patients receiving chlorpromazine: responses to 5-hydroxytryptamine, dopamine and N-dimethyl dopamine.
Boullin DJ; Grimes RP
Br J Clin Pharmacol; 1976 Aug; 3(4):649-53. PubMed ID: 22216508
[TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of chlorpromazine, imipramine and papaverine on the blood platelet function].
Bartel' V; Gluza E; Markvardt F
Farmakol Toksikol; 1976; 39(3):296-301. PubMed ID: 193725
[TBL] [Abstract][Full Text] [Related]
16. Effects of reserpine and chlorpromazine on 5-hydroxytryptamine uptake of platelets from migrainous and control subjects.
Hilton BP
J Neurol Neurosurg Psychiatry; 1974 Jun; 37(6):711-4. PubMed ID: 4844137
[TBL] [Abstract][Full Text] [Related]
17. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
Boullin DJ; Grimes RP; Orr MW
Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
[TBL] [Abstract][Full Text] [Related]
18. Acetal phosphatidic acids: novel platelet aggregating agents.
Brammer JP; Maguire MH; Walaszek EJ; Wiley RA
Br J Pharmacol; 1983 May; 79(1):157-66. PubMed ID: 6871540
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors.
Born GV; Dearnley R; Foulks JG; Sharp DE
J Physiol; 1978 Jul; 280():193-212. PubMed ID: 99512
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
